REPROCELL (Germany) Performance
| 6RC Stock | EUR 0.57 0.00 0.00% |
The company holds a Beta of 0.51, which implies possible diversification benefits within a given portfolio. As returns on the market increase, REPROCELL's returns are expected to increase less than the market. However, during the bear market, the loss of holding REPROCELL is expected to be smaller as well. REPROCELL currently holds a risk of 11.72%. Please check REPROCELL jensen alpha, value at risk, and the relationship between the information ratio and total risk alpha , to decide if REPROCELL will be following its historical price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days REPROCELL has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, REPROCELL is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
1 | How ReproCELL Incorporated stock performs in volatility spikes - Market Performance Report Real-Time Buy Zone Alerts - newser.com | 11/04/2025 |
2 | Is ReproCELL Incorporated stock a defensive play amid uncertainty - July 2025 Snapshot Weekly Watchlist for Hot Stocks - newser.com | 11/13/2025 |
3 | Why ReproCELL Incorporated stock remains top rated - Long Setup AI Enhanced Trade Execution Alerts - newser.com | 11/20/2025 |
4 | How buyback programs support ReproCELL Incorporated stock - Portfolio Performance Summary Fast Entry High Yield Tips - Newser | 12/04/2025 |
5 | REPROCELL Launches StemEdit - Clinical Gene Editing Services and New iPSC Lines Using AI-Designed editing tools - PR Newswire | 01/28/2026 |
| Begin Period Cash Flow | 2.9 B | |
| Free Cash Flow | -89.9 M |
REPROCELL |
REPROCELL Relative Risk vs. Return Landscape
If you would invest 77.00 in REPROCELL on November 6, 2025 and sell it today you would lose (20.00) from holding REPROCELL or give up 25.97% of portfolio value over 90 days. REPROCELL is generating 0.0664% of daily returns assuming 11.7223% volatility of returns over the 90 days investment horizon. Simply put, majority of traded equity instruments are less risky than REPROCELL on the basis of their historical return distribution, and most equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
REPROCELL Target Price Odds to finish over Current Price
The tendency of REPROCELL Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.57 | 90 days | 0.57 | about 83.52 |
Based on a normal probability distribution, the odds of REPROCELL to move above the current price in 90 days from now is about 83.52 (This REPROCELL probability density function shows the probability of REPROCELL Stock to fall within a particular range of prices over 90 days) .
REPROCELL Price Density |
| Price |
Predictive Modules for REPROCELL
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as REPROCELL. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.REPROCELL Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. REPROCELL is not an exception. The market had few large corrections towards the REPROCELL's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold REPROCELL, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of REPROCELL within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.07 | |
β | Beta against Dow Jones | 0.51 | |
σ | Overall volatility | 0.09 | |
Ir | Information ratio | -0.0089 |
REPROCELL Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of REPROCELL for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for REPROCELL can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| REPROCELL had very high historical volatility over the last 90 days | |
| REPROCELL has some characteristics of a very speculative penny stock | |
| Latest headline from news.google.com: REPROCELL Launches StemEdit - Clinical Gene Editing Services and New iPSC Lines Using AI-Designed editing tools - PR Newswire |
REPROCELL Fundamentals Growth
REPROCELL Stock prices reflect investors' perceptions of the future prospects and financial health of REPROCELL, and REPROCELL fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on REPROCELL Stock performance.
| Current Valuation | 50.22 M | ||||
| Price To Book | 1.14 X | ||||
| Price To Sales | 3.76 X | ||||
| Revenue | 2.98 B | ||||
| EBITDA | (513.85 M) | ||||
| Net Income | 103.25 M | ||||
| Total Debt | 685.81 M | ||||
| Cash Flow From Operations | 6.29 M | ||||
| Total Asset | 9.67 B | ||||
| Retained Earnings | 58.29 M | ||||
About REPROCELL Performance
By analyzing REPROCELL's fundamental ratios, stakeholders can gain valuable insights into REPROCELL's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if REPROCELL has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if REPROCELL has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
REPROCELL is entity of Germany. It is traded as Stock on BE exchange.Things to note about REPROCELL performance evaluation
Checking the ongoing alerts about REPROCELL for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for REPROCELL help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| REPROCELL had very high historical volatility over the last 90 days | |
| REPROCELL has some characteristics of a very speculative penny stock | |
| Latest headline from news.google.com: REPROCELL Launches StemEdit - Clinical Gene Editing Services and New iPSC Lines Using AI-Designed editing tools - PR Newswire |
- Analyzing REPROCELL's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether REPROCELL's stock is overvalued or undervalued compared to its peers.
- Examining REPROCELL's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating REPROCELL's management team can have a significant impact on its success or failure. Reviewing the track record and experience of REPROCELL's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of REPROCELL's stock. These opinions can provide insight into REPROCELL's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for REPROCELL Stock analysis
When running REPROCELL's price analysis, check to measure REPROCELL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy REPROCELL is operating at the current time. Most of REPROCELL's value examination focuses on studying past and present price action to predict the probability of REPROCELL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move REPROCELL's price. Additionally, you may evaluate how the addition of REPROCELL to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |